LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships
- Written by The Bulletin
ANDERNACH, GERMANY - Newsaktuell - 14 January 2025 - LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company, is proud to announces its selection as a Concept Stage winner for two projects in the #PatchForwardPrize, a $50 million challenge by the Biomedical Advanced Research and Development Authority (BARDA) to advance microneedle patch-based RNA vaccine technologies.
Read more: LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships
